Good news for the HeartMate 3 (Abbott Cardiovascular) as a bridge to heart transplantation: in the 2 years following US Food and Drug Administration approval of the left ventricular assist device ...
Thousands of HVADs could have faulty battery cells. Nancy Crotti HeartWare International is recalling more than 18,000 batteries for ventricular assist devices it sold between 2013 and 2015, the ...
With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.
Abbott Laboratories, Inc. (ABT Quick Quote ABT - Free Report) recently announced that the FDA has approved a change of label for its HeartMate 3 left ventricular assist device (LVAD or heart pump).
Hundreds of HeartMate 3 left ventricular assist device (LVAD) systems are being recalled due to reports of blood leakage or air entering the seal interface between the device inflow cannula and the ...
New data from the MOMENTUM 3 study showed for the first time that a heart pump can extend survival to five years and beyond for advanced heart failure patients Prior data1 have shown survival for ...
PONTE VEDRA, Fla.--(BUSINESS WIRE)--Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapeutics, with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results